Contemporary population estimates suggest that like cigarette-only smokers, current cigar-only and pipe-only smokers have a higher risk of dying from cancers known to be caused by tobacco, and cigarette and cigar smokers have a higher risk of death from any cause compared with people who never used tobacco.
Massachusetts General Hospital physician Nancy Rigotti, M.D., outlines what is and is not known about the risks and benefits of e-cigarettes in a commentary published in the Feb. 13 issue of Annals of Internal Medicine.
New research shows that the NHS should consider working with reputable vape shops to help smokers quit. The study finds that vape shops provide behavioral support which could help people stop smoking and remain smoke free.
The vapor from e-cigarettes seems to help pneumonia-causing bacteria stick to the cells that line the airways, according to research published in the European Respiratory Journal.
Scientists at British American Tobacco used state-of-the-art genomic testing to assess human air-way tissue exposed to glo vapour. Gene profiling revealed just two changes in genes in tissue exposed to glo vapour. This compares to thousands of changes in genes in tissue exposed to cigarette smoke. These results add to evidence suggesting that glo could be reduced risk compared to cigarettes.
The results of this ISGlobal study strengthen the epidemiological evidence supporting a link between physical activity and respiratory health
Although tobacco control measures have reduced overall smoking rates in the United States, a new report says several vulnerable subpopulations continue to smoke at high rates.
A new study adds to growing evidence on the harmful health effects of e-cigarettes. The study finds that exposure to commonly used e-cigarette flavoring chemicals and liquids can cause significant inflammation to monocytes, a type of white blood cell. Moreover, many flavoring compounds are toxic, with cinnamon, vanilla and buttery flavors among the worst. It also finds that mixing e-cigarette flavors has a much worse effect than exposure to just one.
A new Tel Aviv University study published in Addiction finds that only eight out of 100 smokers who take smoking cessation medications will have benefited from taking smoking medications after one year's time.
In a six-month study recently concluded, a research unit affiliated with two hospital institutions and a university in Ottawa found that a reduction in the number of cigarettes smoked daily also reduced a smoker's dependence on opioids.